- Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon
- Author: Mr Mfazo Hove
- Published: March 23, 2025
- Last Updated: September 11, 2026
TL;DR: The honest answer to “is it worth getting eye laser surgery?” is that, for the right eyes, it is emphatically worth it, and for the wrong eyes, it is not worth it at any price. Well-selected laser surgery carries world literature satisfaction around 95%,¹ and the phrase doing the quiet work in that sentence is “well-selected”.
So, this is the gatekeeper page, the appropriateness question in full: the eight things I want to know before saying yes, how your age changes the answer, when LASIK is wrong but laser is still right, when laser is wrong but refractive surgery is still right, four patients I would advise differently, and what would make me stop an assessment. Money is deliberately absent; the value and package analysis lives at Is Laser Eye Surgery Worth It? A Life-Changing Investment.
The 8 Things I Want to Know Before Saying Yes
- Your age. Age is a proxy for two things: refractive stability, since young prescriptions may still be moving, and lens status, since from the mid-40s the natural lens begins stiffening into presbyopia and eventually clouding. Neither forbids laser; both shape the recommendation, which is why age gets its own section below.
- A genuinely stable refraction. Surgery corrects the prescription you have, not the one still moving, so I want evidence of stability across recent records, not a single sight test. Lasering a moving target buys yesterday’s correction, and stability is also one of the written eligibility criteria in our enhancement policy for good reason: it protects the result at both ends.
- Corneal thickness. The laser corrects by removing tissue, so your cornea must hold enough to fund the correction and retain a robust reserve afterwards. Pachymetry measures this precisely, and a correction that overdraws the tissue budget is declined, not discounted.
- Corneal shape, on topography and tomography. The map matters more than the number. Screening exists above all to detect the cornea that should not be lasered: a rare but potentially serious late complication, ectasia, involves progressive weakening and distortion of the cornea, and careful shape analysis is designed to minimise that risk, although no responsible surgeon should imply biological risk can ever be reduced to zero.⁴
- Your ocular surface. Dry eye is among the most common aftermaths of laser surgery and significantly worse when it precedes it,⁶ so the surface is examined honestly and treated first, not lasered through. A clinic that never mentions your tear film at assessment has skipped a page of your protection.
- Prescription magnitude. Moderate corrections are laser’s home ground; very high ones demand more tissue than corneas should give and sit more naturally in a lens-based solution. The number alone never decides, but it steers, in combination with points 3 and 4.
- Your natural lens, and where you are on the presbyopia curve. If near vision is already fading, or the lens shows early change, the honest question becomes which structure to treat and answering it requires a practice that can genuinely offer both roads.
- Expectations, occupation and lifestyle. Night-critical work weighs early dysphotopsia differently; contact sport weighs flap decisions; perfectionism about night optics weighs everything. The measurements decide whether laser is possible; this conversation decides whether it will make you happy, and both are my job.
Your Age Changes the Answer
In your 20s, laser is often straightforward once stability is proven, with decades of full return ahead. In your 30s, frequently the sweet spot: stable prescriptions, healthy lenses, prime laser territory. In your 40s, presbyopia enters the calculation: laser still serves distance superbly, PRESBYOND® extends near function for suitable patients, and the lens-based comparison starts to deserve a hearing, made properly in Lens Replacement vs Laser Eye Surgery in Your 40s.
In your 50s, lens status increasingly leads: an ageing or early-clouding lens usually makes lens surgery the honest first conversation, with laser reserved for the corneal minority. The operation does not change across those decades; the right question does.
When LASIK Is Wrong but Laser Is Still Right
“Not suitable for LASIK” is frequently not “not suitable for laser”. Thinner corneas, certain surface profiles, particular occupations and contact-sport lifestyles can argue against a flap while leaving surface treatment, PRK or LASEK, entirely appropriate, at the cost of a slower early recovery; and SMILE’s flapless keyhole profile suits others. The evidence supports these as different tools rather than rankings,³ which is why a one-platform clinic answers a narrower question than the one you asked.
When Laser Is Wrong but Refractive Surgery Is Still Right
And “not suitable for laser” is frequently not “not suitable”. The ICL corrects vision without removing corneal tissue, with a strong published safety and effectiveness record,⁵ and is the honest alternative, not the consolation prize, for thin corneas and high myopia.
Lens replacement is the honest road once the ageing lens is the real problem. A practice offering only laser has fewer alternative pathways available when laser is not the best solution; because Blue Fin Vision® offers all three, the recommendation can follow your eye.
Four Patients I Would Advise Differently
- 28, minus 3.00, healthy corneas, stable for years. Likely laser, with technique chosen on the maps and lifestyle; modern outcome series describe exactly this patient’s excellent prospects.²
- 31, minus 9.00, thin corneas. Think ICL first: the correction is large, the tissue budget is not, and preserving the cornea while an implanted lens carries the prescription is the conservative, usually happier road.
- 47, plus 2.50, struggling with reading. Run the PRESBYOND and lens comparison honestly before treating anything: hyperopia plus presbyopia is lens-tilted territory, and the right answer may be blended vision now, lens surgery later, or lens surgery now, depending on the measurements and the life.
- 40, suspicious tomography. No corneal laser, whatever the disappointment: the map is the verdict, the ICL discussion is open, and a clinic that would proceed anyway has failed the only test that matters.
What Would Make Me Stop an Assessment?
The list is short and non-negotiable:
- A shape map I do not trust.
- A tissue budget the correction would overdraw.
- A refraction that is still moving.
- A surface that needs treatment first.
- A lens that is already the real problem.
- Expectations that no optics can meet.
Stopping is not a failed consultation; it is the qualification doing its work, and it is precisely what the Royal College of Ophthalmologists’ CertLRS, the College’s dedicated examination and certificate in refractive surgery, examines a surgeon’s judgement for. A credible laser assessment must be capable of ending with a recommendation not to proceed, or to proceed differently.
A service in which virtually every assessed patient proceeds deserves scrutiny, because genuine refractive assessment should identify some eyes in which corneal laser is not the best option.
The belief runs close to home, too: the Practice Manager at Blue Fin Vision® has had laser eye surgery herself, performed at Blue Fin Vision®. When the person responsible for running the clinic chooses the Blue Fin Vision® surgical pathway for her own eyes, that makes confidence in the service personal rather than purely corporate.
So, Is It Worth Getting Eye Laser Surgery?
If the eight questions above come back in your favour: yes, on some of the best evidence in elective medicine.¹ ² If any come back against you, the worth evaporates regardless of the discount, and the honest answer is a different technique, a different operation, or patience.
Find out which option may suit your eyes by booking a complimentary laser eye surgery consultation with Blue Fin Vision®. You can discuss your options with our consultant-led UK team at locations across London, Hertfordshire and Essex.
Bring the Laser Eye Surgery Checklist to Blue Fin Vision® and anyone else you are considering and let the measurements answer the question the internet cannot.
References
- Solomon KD, Fernández de Castro LE, Sandoval HP, Biber JM, Groat B, Neff KD, Ying MS, French JW, Donnenfeld ED, Lindstrom RL; Joint LASIK Study Task Force. LASIK world literature review: quality of life and patient satisfaction. Ophthalmology. 2009;116(4):691-701. PMID: 19344821.
- Sandoval HP, Donnenfeld ED, Kohnen T, Lindstrom RL, Potvin R, Tremblay DM, Solomon KD. Modern laser in situ keratomileusis outcomes. J Cataract Refract Surg. 2016;42(8):1224-1234. PMID: 27531300.
- Shortt AJ, Allan BD, Evans JR. Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia. Cochrane Database Syst Rev. 2013;(1):CD005135. PMID: 23440799.
- Randleman JB, Woodward M, Lynn MJ, Stulting RD. Risk assessment for ectasia after corneal refractive surgery. Ophthalmology. 2008;115(1):37-50. PMID: 17624434.
- Packer M. Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lens. Clin Ophthalmol. 2016;10:1059-1077. PMID: 27354760.
- Ambrósio R Jr, Tervo T, Wilson SE. LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment. J Refract Surg. 2008;24(4):396-407. PMID: 18500091.
ABOUT THE AUTHOR
Mr Mfazo Hove
Consultant Ophthalmic Surgeon
MBChB MD FRCOphth CertLRS
Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with experience spanning more than 57,000 procedures. He completed 6.5 years of specialist training at Moorfields Eye Hospital and served for five years as a consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust. He is the founder of Blue Fin Vision®, a consultant-led private ophthalmology practice operating across London, Essex, and Hertfordshire. His clinical expertise encompasses advanced cataract surgery, refractive lens replacement, laser vision correction, and implantable Collamer lenses (ICL).
A ZEISS Key Opinion Leader, Mr Hove is a respected international speaker with five invited engagements across seven cities in 2026:
- ZEISS China tour (Changsha, Shanghai, and Hangzhou, April – ZEISS APAC User Meeting)
- RCOphth Annual Congress – May – Manchester
- ZEISS EMEA User Meeting (Istanbul)
- ZEISS Lausanne User Meeting (Lausanne)
- European Society of Cataract and Refractive Surgeons Annual Congress (ESCRS, London)
